Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Clinical Research›Case-Control Studies
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Case-Control Studies

Clinical Research · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (876 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Case-Control Study; Studies, Case-Control; Study, Case-Control; Case-Comparison Studies; Case Comparison Studies; Case-Comparison Study; Studies, Case-Comparison; Study, Case-Comparison.

Where it fits in the MeSH classification

Broader topics
Epidemiologic Studies
Narrower topics
Retrospective Studies

Research landscape

PubMed indexes 1,759,224 records tagged with the MeSH heading “Case-Control Studies” (counts retrieved 2026-10-29). 666,050 of them (37.9%) were published from 2020 onward, and the busiest period so far is 2020 onward with 666,050 records.

Reviews account for 50,870 records (2.9%) and meta-analyses for 15,248. Randomized controlled trials number 15,189 (0.9%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 140,094 records; 2000-2009: 294,808 records; 2010-2019: 658,272 records; 2020 onward: 666,050 records140,094through 1999294,8082000-2009658,2722010-2019666,0502020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999140,094
2000-2009294,808
2010-2019658,272
2020 onward666,050
Share of records by publication typeReviews: 2.9 percent; Meta-analyses: 0.9 percent; Randomized controlled trials: 0.9 percentReviews2.9% (50,870)Meta-analyses0.9% (15,248)Randomized controlled trials0.9% (15,189)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,759,224 PubMed records
TypeRecordsShare
Reviews50,8702.9%
Meta-analyses15,2480.9%
Randomized controlled trials15,1890.9%

Method: PubMed query "Case-Control Studies"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in clinical research

Research methods determine how much a result can be trusted. Randomized trials guard against confounding, systematic reviews and meta-analyses combine many studies, and observational designs are valuable but can show only association. Reporting standards, trial registration and pre-specified outcomes reduce bias. When reading about a method, ask what problem it is designed to solve and which problems it does not solve.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology
Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, et al.
2005Research article
Design not recorded in structured metadata
111cc by
PMID 16079783 · DOI · PMC2361558
The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study
Tseng CM, Chen YT, Ou SM, Hsiao YH, Li SY, Wang SJ, et al.
2013Randomized controlled trial
Design not recorded in structured metadata
94cc by
PMID 23554858 · DOI · PMC3598847
The definition and measurement of heterogeneity
Nunes A, Trappenberg T, Alda M
2020Review article
Design not recorded in structured metadata
41cc by
PMID 32839448 · DOI · PMC7445182
Collapsibility in case-control studies
Pearce N
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42217164 · DOI · PMC13221832

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology [1]

Research article Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, et al. · · 2005 · cited 111 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Reproductive factors are associated with reduced risk of breast cancer, but less is known about whether there is differential protection against subtypes of breast cancer.
Closing excerpt
This study also suggests that reproductive factors have similar protective effects on breast tumours of lobular and ductal origin.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (258 words)

Reproductive factors are associated with reduced risk of breast cancer, but less is known about whether there is differential protection against subtypes of breast cancer. Assuming reproductive factors act through hormonal mechanisms they should protect predominantly against cancers expressing oestrogen (ER) and progesterone (PR) receptors. We examined the effect of reproductive factors on subgroups of tumours defined by hormone receptor status as well as histology using data from the NIHCD Women's Contraceptive and Reproductive Experiences (CARE) Study, a multicenter case-control study of breast cancer. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) as measures of relative risk using multivariate unconditional logistic regression methods. Multiparity and early age at first birth were associated with reduced relative risk of ER + PR + tumours (P for trend=0.0001 and 0.01, respectively), but not of ER - PR - tumours (P for trend=0.27 and 0.85), whereas duration of breastfeeding was associated with lower relative risk of both receptor-positive (P for trend=0.0002) and receptor-negative tumours (P=0.0004). Our results were consistent across subgroups of women based on age and ethnicity. We found few significant differences by histologic subtype, although the strongest protective effect of multiparity was seen for mixed ductolobular tumours. Our results indicate that parity and age at first birth are associated with reduced risk of receptor-positive tumours only, while lactation is associated with reduced risk of both receptor-positive and -negative tumours. This suggests that parity and lactation act through different mechanisms. This study also suggests that reproductive factors have similar protective effects on breast tumours of lobular and ductal origin.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 16079783 · DOI · PMC2361558

The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study [2]

Randomized controlled trial Tseng CM, Chen YT, Ou SM, Hsiao YH, Li SY, Wang SJ, et al. · · 2013 · cited 94 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundSeasonal variations in the acute exacerbation of chronic obstructive pulmonary disease (COPD) have been reported.
Closing excerpt
A more comprehensive program to prevent cold stress in COPD patients may lead to a reduction in the exacerbations rate of COPD.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (195 words)

BackgroundSeasonal variations in the acute exacerbation of chronic obstructive pulmonary disease (COPD) have been reported. However, the influence of air temperature and other meteorological factors on COPD exacerbation remains unclear.MethodsNational Health Insurance registry data from January 1, 1999 to December 1, 2009 and meteorological variables from the Taiwan Central Weather Bureau for the same period were analyzed. A case-crossover study design was used to investigate the association between COPD exacerbation and meteorological variables.ResultsA total of 16,254 cases who suffered from COPD exacerbation were enrolled. We found that a 1°C decrease in air temperature was associated with a 0.8% increase in the exacerbation rate on event-days (95% confidence interval (CI), 1.015-1.138, p = 0.015). With a 5°C decrease in mean temperature, the cold temperature (28-day average temperature) had a long-term effect on the exacerbation of COPD (odds ratio (OR), 1.106, 95% CI 1.063-1.152, pConclusionsThis study demonstrated the effect of cold temperatures on the COPD exacerbation rate. Elderly patients and those without inhaled medicine before the exacerbation event were affected significantly by lower mean temperatures. A more comprehensive program to prevent cold stress in COPD patients may lead to a reduction in the exacerbations rate of COPD.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 23554858 · DOI · PMC3598847

The definition and measurement of heterogeneity [3]

Review article Nunes A, Trappenberg T, Alda M · · 2020 · cited 41 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Heterogeneity is an important concept in psychiatric research and science more broadly.
Closing excerpt
However, significant limitations must be overcome for these measures-largely developed for economic and ecological research-to be useful in modern translational psychiatric science.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (201 words)

Heterogeneity is an important concept in psychiatric research and science more broadly. It negatively impacts effect size estimates under case-control paradigms, and it exposes important flaws in our existing categorical nosology. Yet, our field has no precise definition of heterogeneity proper. We tend to quantify heterogeneity by measuring associated correlates such as entropy or variance: practices which are akin to accepting the radius of a sphere as a measure of its volume. Under a definition of heterogeneity as the degree to which a system deviates from perfect conformity, this paper argues that its proper measure roughly corresponds to the size of a system's event/sample space, and has units known as numbers equivalent. We arrive at this conclusion through focused review of more than 100 years of (re)discoveries of indices by ecologists, economists, statistical physicists, and others. In parallel, we review psychiatric approaches for quantifying heterogeneity, including but not limited to studies of symptom heterogeneity, microbiome biodiversity, cluster-counting, and time-series analyses. We argue that using numbers equivalent heterogeneity measures could improve the interpretability and synthesis of psychiatric research on heterogeneity. However, significant limitations must be overcome for these measures-largely developed for economic and ecological research-to be useful in modern translational psychiatric science.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32839448 · DOI · PMC7445182

Collapsibility in case-control studies [4]

Research article Pearce N · · 2026

Abstract reading summary — source excerpts
Opening excerpt
It is well-established that the odds ratio (OR) is non-collapsible and that adjustment of the OR for a risk factor can produce a change in the main effect estimate even when there is no confounding.
Closing excerpt
Moreover, if the disease under study is rare (in the cohort study), all three methods produce case-control ORs that are approximately collapsible.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (222 words)

It is well-established that the odds ratio (OR) is non-collapsible and that adjustment of the OR for a risk factor can produce a change in the main effect estimate even when there is no confounding. In contrast, the risk ratio (RR) is collapsible, whereas the rate ratio is non-collapsible, but usually to a lesser extent than is the case with ORs. However, almost all discussions of non-collapsibility have been conducted in the context of effect measures in cohort studies. In this paper, I consider non-collapsibility in case-control studies where the OR inherits the collapsibility or non-collapsibility of the ratio effect measure that the study was designed to estimate. This is most clearly illustrated in the situation of a closed cohort with a fixed follow-up time. In this situation, choosing controls by cumulative incidence sampling estimates the OR in the corresponding cohort study, and therefore the resulting case-control OR is non-collapsible. Choosing controls by case-cohort sampling estimates the cohort study RR, and the resulting case-control OR is collapsible. Choosing controls by density sampling (perhaps the most common approach) estimates the cohort study rate ratio, and the resulting case-control OR is non-collapsible, but to a lesser extent than for cumulative incidence sampling. Moreover, if the disease under study is rare (in the cohort study), all three methods produce case-control ORs that are approximately collapsible.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42217164 · DOI · PMC13221832

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Observational research methods. Research design II: cohort, cross sectional, and case-control studies [5]
    Mann CJ · Emerg Med J · 2003 · cited 808 times (Europe PMC)
  • Research article Observational studies: cohort and case-control studies [6]
    Song JW, Chung KC · Plast Reconstr Surg · 2010 · cited 616 times (Europe PMC)
  • Research article Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies [7]
    Greenland S · Am J Epidemiol · 2004 · cited 573 times (Europe PMC)
  • Research article Should we use a case-crossover design? [8]
    Maclure M, Mittleman MA · Annu Rev Public Health · 2000 · cited 529 times (Europe PMC)
  • Research article Retrospective studies - utility and caveats [9]
    Talari K, Goyal M · J R Coll Physicians Edinb · 2020 · cited 466 times (Europe PMC)
  • Research article Case-control and two-gate designs in diagnostic accuracy studies [10]
    Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM · Clin Chem · 2005 · cited 378 times (Europe PMC)

References

  1. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, et al.. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. . 2005. PMID 16079783 · DOI · PMC2361558
  2. Tseng CM, Chen YT, Ou SM, Hsiao YH, Li SY, Wang SJ, et al.. The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study. . 2013. PMID 23554858 · DOI · PMC3598847
  3. Nunes A, Trappenberg T, Alda M. The definition and measurement of heterogeneity. . 2020. PMID 32839448 · DOI · PMC7445182
  4. Pearce N. Collapsibility in case-control studies. . 2026. PMID 42217164 · DOI · PMC13221832
  5. Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003. PMID 12533370 · DOI · PMC1726024
  6. Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010. PMID 20697313 · DOI · PMC2998589
  7. Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004. PMID 15286014 · DOI
  8. Maclure M, Mittleman MA. Should we use a case-crossover design?. Annu Rev Public Health. 2000. PMID 10884952 · DOI
  9. Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020. PMID 33469615 · DOI
  10. Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005. PMID 15961549 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Epidemiologic StudiesClinical Research
  • Feasibility StudiesClinical Research
  • Prospective StudiesClinical Research
  • Retrospective StudiesClinical Research
  • Follow-Up StudiesClinical Research
  • Cohort StudiesClinical Research

All 98 articles in Clinical Research →

At a glance

1,759,224
PubMed records on this heading
38%
published since 2020
50,870
review articles
15,189
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Epidemiologic StudiesClinical Research
  • Feasibility StudiesClinical Research
  • Prospective StudiesClinical Research
  • Retrospective StudiesClinical Research
  • Follow-Up StudiesClinical Research

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support